Searchable abstracts of presentations at key conferences in endocrinology

ea0032p770 | Obesity | ECE2013

Testosterone concentrations in obesity, an outcome of lipotoxicity?

Bekaert Marlies , Van Nieuwenhove Yves , Calders Patrick , Kaufman Jean-Marc , Ouwens Margriet , Ruige Johannes

Objective: Testosterone levels are decreased in male obesity, the mechanism of which is incompletely understood. The aim of this study was to explore determinants affecting the feedback mechanism of the hypothalamic–pituitary–gonadal axis in male obesity and type 2 diabetes (DM2), such as aromatase expression and lipotoxicity.Materials and methods: Circulating levels of testosterone were quantified (<1000 h with LC–MS/MS) in 37 middle-...

ea0049ep1191 | Steroid metabolism + action | ECE2017

Non-alcoholic fatty liver disease and its relation with sex steroids in men

Van de Velde Frederique , Van Nieuwenhove Yves , Bekaert Marlies , Hoorens Anne , Praet Marleen , Kaufman Jean-Marc , Lapauw Bruno

Background: Obesity associates with co-morbidities as non-alcoholic fatty liver disease (NAFLD). Obese men often present with low testosterone (T) levels. As sex steroids undergo hepatic metabolization and their serum levels depend on hepatic sex hormone binding globulin (SHBG) secretion, NAFLD could contribute to this phenomenon. Previous studies however were contradictory and not based on state-of-the-art technology as mass spectrometry or biopsy-proven NAFLD.<p class="a...

ea0057022 | Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population | BES2018

Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population

Frederique Van de Velde , Marlies Bekaert , Anne Hoorens , Marleen Praet , Arsene-Helene Batens , Shadid S , Yves Van Nieuwenhove , Bruno Lapauw

Background: Obesity induced inflammation is a key component in the pathogenesis of insulin resistance (IR). In addition, obesity-related non-alcoholic fatty liver disease (NAFLD) also seems to contribute to IR development. Until now, however, it is unclear which, if any component of NAFLD specifically associates with IR. Therefore, the aim is to assess if individual components of NAFLD contribute to IR in obese patients undergoing gastric bypass surgery (GBS).<p class="abs...

ea0056p531 | Obesity | ECE2018

Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population

Velde Frederique Van de , Bekaert Marlies , Hoorens Anne , Praet Marleen , Batens Arsene-Helene , Shadid Samyah , Nieuwenhove Yves Van , Lapauw Bruno

Background and aims: Obesity induced inflammation is a key component in the pathogenesis of insulin resistance (IR). In addition, obesity-related non-alcoholic fatty liver disease (NAFLD) also seems to contribute to IR development. Until now, however, it is unclear which, if any component of NAFLD specifically associates with IR. Therefore, the aim is to assess if individual components of NAFLD contribute to IR in obese patients undergoing gastric bypass surgery (GBS).<p c...

ea0041ep787 | Obesity | ECE2016

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in obese patients

Bekaert Marlies , Margriet Ouwens D , Horbelt Tina , Van de Velde Frederique , Van Nieuwenhove Yves , Calders Patrick , Praet Marleen , Geerts Anja , Verhelst Xavier , Kaufman Jean-Marc , Lapauw Bruno

Aims: Emerging data indicate that an impaired release of adipose tissue-derived adipokines could play a pivotal role in the development of non-alcoholic fatty liver disease (NAFLD). We aimed to evaluate whether circulating levels or visceral adipose tissue (VAT) expression of recently described adipokines associate with the histopathological disease severity and thus may contribute to the progression of pure fatty liver into an inflammatory and insulin resistant NASH status.</...